Factorial Analysis of the Cardiometabolic Risk Influence on Redox Status Components in Adult Population

Table 4

Estimated odds ratios after ordinal regression analysis for tSHG, PAB, and PAB/tSHG tertiles, respectively, as dependent variable.

Unadjusted
tSHG tertiles as dependent variable	OR (95% CI)		Nagelkerke
BMI	1.046; (0.957-1.097)	0.072	0.013
WC	1.029; (1.011-1.049)	0.002	0.038
WHtR	2.27; (2.19-2.37)	0.022	0.037
HDL-c	0.281; (0.164-0.481)	<0.001	0.086
TG	2.337; (1.784-3.062)	<0.001	0.170
VAI	1.560; (1.339-1.820)	<0.001	0.158
LAP	1.015; (1.010-1.020)	<0.001	0.144
siMS score	2.020; (1.600-2.550)	<0.001	0.148
Adjusted
Model	OR (95% CI)		Nagelkerke
WC	1.011; (0.989-1.033)	0.319	0.088
WHtR	0.128; (0.065-0.325)	0.069	0.121
HDL-c	0.359; (0.199-0.646)	0.001	0.126
TG	2.333; (1.754-3.102)	<0.001	0.220
VAI	1.540; (1.310-1.811)	<0.001	0.204
LAP	1.015; (1.009-1.021)	<0.001	0.192
Unadjusted
PAB tertiles as dependent variable	OR (95% CI)		Nagelkerke
BMI	0.978; (0.932-1.026)	0.371	0.013
WC	0.985; (0.967-1.003)	0.104	0.010
HDL-c	1.976; (1.185-3.294)	0.009	0.027
TG	0.924; (0.768-1.112)	0.401	0.002
VAI	1.001; (0.924-1.083)	0.988	0
LAP	0.999; (0.996-1.003)	0.677	0.001
siMS score	0.840; (0.694-1.017)	0.075	0.012
Adjusted
Model	OR (95% CI)		Nagelkerke
HDL-c	1.142; (0.640-2.056)	0.653	0.136
Unadjusted
PAB/tSHG tertiles as dependent variable	OR (95% CI)		Nagelkerke
BMI	0.970; (0.924-1.019)	0.217	0.006
WC	0.978; (0.959-0.995)	0.014	0.024
HDL-c	3.699; (2.145-6.360)	<0.001	0.088
TG	0.742; (0.467-0.749)	<0.001	0.088
VAI	0.784; (0.691-1.124)	<0.001	0.075
LAP	0.992; (0.987-0.996)	<0.001	0.062
siMS score	0.603; (0.486-0.748)	<0.001	0.090
Adjusted
Model	OR (95% CI)		Nagelkerke^2
WC	1.014; (0.991-1.039)	0.231	0.164
HDL-c	2.206; (1.214-4.011)	0.009	0.181
TG	0.602; (0.466-0.788)	<0.001	0.216
VAI	0.810; (0.709-0.925)	0.002	0.200
LAP	0.993; (0.988-0.998)	0.010	0.185

Data are given as OR (95% CI). Adjusted model for tSHG: Model included each marker and continuous (HbA1c, GGT, and uric acid) and categorical variables (diabetes presence, antilipemic therapy, and gender). Adjusted model for PAB: Model included continuous variables: age, HbA1c, hsCRP, GGT, uric acid, and categorical variables: diabetes presence, antihypertensive therapy, and gender. Adjusted model for PAB/tSHG: Model included continuous variables: age, HbA1c, GGT, uric acid, and categorical variables: diabetes presence, antihypertensive and antilipemic therapy, and gender.